Filing Flows

Filing Flows › agilon health (AGL) › Q2 2026 › vs Q1 2026

agilon health (AGL) Q2 2026 vs Q1 2026 (quarter over quarter)

agilon health's revenue rose $74.3M (+5%) from $1.4B in Q1 2026 to $1.5B in Q2 2026. The biggest changes: Medical services revenue +$74.4M (+5%); Other operating revenue −$89K (-5%). Operating margin 0.8% against 0.3% (+0.5 pts).

agilon health, Q2 2026: revenue $1.5B (+7% year over year), operating margin 0.8%, net earnings $18.0M, operating cash flow −$57.3M. The chart draws each line against Q1 2026, the increases inside each band.

agilon health: what changed, Q2 2026 vs Q1 2026agilon health: what changed, Q2 2026 vs Q1 2026Cash used in operations$81.0MMedical services revenue$74.4MOperating cash sources$67.7MWorking capital & other$67.7MCosts & expenses$66.5MOther income, net−$39.1MGeneral & admin$34.3MOther operating costs$32.2MPre-tax earnings−$31.4MNet earnings−$31.0M

Margins

Q2 2026Q1 2026Change
Operating margin0.8%0.3%+0.5 pts
Net margin1.2%3.4%-2.2 pts

Every line

LineQ2 2026Q1 2026Change%
Medical services revenue$1.5B$1.4B$74.4M+5%
Other operating revenue$1.8M$1.9M−$89K-5%
Revenue$1.5B$1.4B$74.3M+5%
Other income, net$5.8M$44.9M−$39.1M-87%
Operating profit$11.8M$4.0M$7.8M+194%
Costs & expenses$1.5B$1.4B$66.5M+5%
Pre-tax earnings$17.6M$48.9M−$31.4M-64%
General & admin$88.5M$54.2M$34.3M+63%
Other operating costs$1.4B$1.4B$32.2M+2%
Income tax benefit$375K−$28K$403K—
Net earnings$18.0M$48.9M−$31.0M-63%
Operating cash sources$106M$38.2M$67.7M+177%
Depreciation & amortization$6.9M$6.8M$77K+1%
Share-based compensation$23.8M$6.3M$17.6M+281%
Cash used in operations$57.3M−$23.7M$81.0M—
Working capital & other$106M$38.2M$67.7M+177%

Questions

How much did agilon health's revenue grow quarter over quarter in Q2 2026?

agilon health's revenue rose $74.3M (+5%) from $1.4B in Q1 2026 to $1.5B in Q2 2026.

What drove agilon health's revenue change in Q2 2026?

Medical services revenue +$74.4M (+5%); Other operating revenue −$89K (-5%).

Q2 2026 results → · Compare in the interactive Sankey →